AMIX NASDAQ
Autonomix Medical, Inc.
1W: -6.0%
1M: -16.0%
3M: -44.1%
YTD: -66.5%
1Y: -84.6%
$3.78
-0.14 (-3.57%)
Weekly Expected Move ±5.5%
$3
$4
$4
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (24h)
1
Hourly Sentiment (24h)
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (19)
Autonomix Medical, Inc. (NASDAQ: AMIX) Gets a Clearer FDA Path
Autonomix Medical more than doubles after $4.9M warrant deal; shares hit $11.63
Autonomix Medical raises up to $2.6M through warrant inducement
12 Health Care Stocks Moving In Friday's After-Market Session
Why 8x8 Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Publication Strategy and Scientific Validation
Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Significant Drop in Short Interest
Autonomix Medical to Present Final Analysis on Pain Mitigation in Pancreatic Cancer at SIO 2026 Annual Scientific Meeting
Short Interest in Autonomix Medical, Inc. (NASDAQ:AMIX) Increases By 1,052.8%
Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium
Autonomix Medical, Inc. Granted European Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology
Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment
Autonomix Medical, Inc. Announces Abstract Selected for Poster Presentation at the 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
Head to Head Analysis: Autonomix Medical (NASDAQ:AMIX) & Nuwellis (NASDAQ:NUWE)
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Highlighting Continued Execution and Strategic Growth